Search research articles
Contact Us
Filters
Showing results (81-90 of 678) with videos related to
Page
of 68
Sort By:
Neuro Endocrinology Letters
|
March 26, 2013
Cerebrospinal fluid concentrations of ghrelin in patients with multiple sclerosis
Marcus M Unger, Wolfgang H Oertel, Bjorn Tackenberg
Clinical Neuropharmacology
|
January 18, 2014
Safety and efficacy of tolcapone in the long-term use in Parkinson disease: an observational study
Karla Eggert, Wolfgang H Oertel, Andrew J Lees, et al.
Pharmacoeconomics
|
December 12, 2001
Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias
R C Dodel, K Berger, W H Oertel
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 14, 1999
Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study
M M Pinter, O Pogarell, W H Oertel
Deutsche Medizinische Wochenschrift (1946)
|
March 27, 1999
[The diagnosis of the parkinsonian syndrome]
J C Möller, O Pogarell, W H Oertel
Journal of the American Geriatrics Society
|
February 1, 1997
Sleep disturbances in Parkinson's disease patients and spouses
M C Smith, H Ellgring, W H Oertel
Neurology
|
November 30, 2000
Safety of pramipexole in patients with restless legs syndrome
K Stiasny, J C Möller, W H Oertel
Journal of Immunology (Baltimore, Md. : 1950)
|
July 1, 1980
The biologic activity of mast cell granules. I. Elicitation of inflammatory responses in rat skin
S Tannenbaum, H Oertel, W Henderson, et al.
Neuroscience Letters
|
June 29, 1984
Immunocytochemical localization of GABA neurons and dopamine neurons in the rat main and accessory olfactory bulbs
E Mugnaini, W H Oertel, F F Wouterlood
Brain Research
|
October 27, 1980
Deafferentation studies on the glutamic acid decarboxylase content of the supraoptic nucleus of the rat
D K Meyer, W H Oertel, M J Brownstein
Page
of 68
Search research articles
Search
Showing results (81-90 of 678) with videos related to
Sort By:
Page
of 68
Neuro Endocrinology Letters
|
March 26, 2013
Cerebrospinal fluid concentrations of ghrelin in patients with multiple sclerosis
Marcus M Unger, Wolfgang H Oertel, Bjorn Tackenberg
Clinical Neuropharmacology
|
January 18, 2014
Safety and efficacy of tolcapone in the long-term use in Parkinson disease: an observational study
Karla Eggert, Wolfgang H Oertel, Andrew J Lees, et al.
Pharmacoeconomics
|
December 12, 2001
Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias
R C Dodel, K Berger, W H Oertel
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 14, 1999
Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study
M M Pinter, O Pogarell, W H Oertel
Deutsche Medizinische Wochenschrift (1946)
|
March 27, 1999
[The diagnosis of the parkinsonian syndrome]
J C Möller, O Pogarell, W H Oertel
Journal of the American Geriatrics Society
|
February 1, 1997
Sleep disturbances in Parkinson's disease patients and spouses
M C Smith, H Ellgring, W H Oertel
Neurology
|
November 30, 2000
Safety of pramipexole in patients with restless legs syndrome
K Stiasny, J C Möller, W H Oertel
Journal of Immunology (Baltimore, Md. : 1950)
|
July 1, 1980
The biologic activity of mast cell granules. I. Elicitation of inflammatory responses in rat skin
S Tannenbaum, H Oertel, W Henderson, et al.
Neuroscience Letters
|
June 29, 1984
Immunocytochemical localization of GABA neurons and dopamine neurons in the rat main and accessory olfactory bulbs
E Mugnaini, W H Oertel, F F Wouterlood
Brain Research
|
October 27, 1980
Deafferentation studies on the glutamic acid decarboxylase content of the supraoptic nucleus of the rat
D K Meyer, W H Oertel, M J Brownstein
Page
of 68